Santoni, Aislinn
Wait, Suzanne
van Boven, Job F. M.
Desson, Zachary
Jenkins, Christine
Khoo, Ee Ming
Winders, Tonya
Yang, Dawei
Yorgancioglu, Arzu
Funding for this research was provided by:
AstraZeneca
Article History
Received: 29 January 2025
Accepted: 27 March 2025
First Online: 19 April 2025
Declarations
:
: Job van Boven reports grants and/or consultancy fees from ALK Abello, Aardex, AstraZeneca, Chiesi, European Commission COST Action 19132 “ENABLE”, European Respiratory Society Clinical Research Collaboration “CONNECT”, GSK, Novartis, Pfizer, Teva, Trudell Medical and Vertex, all outside the submitted work and paid to his institution (UMCG). Christine Jenkins reports grants, consulting fees and honoraria from GSK, AstraZeneca, Sanofi, Chiesi and Menarini. Ee Ming Khoo reports grants from the National Institute for Health Research Global Health Research Unit on Respiratory Health (RESPIRE); personal fees from AstraZeneca; and is a Board director of the International Primary Care Respiratory Group and the President of the Primary Care Respiratory Group Malaysia. Tonya Winders reports consulting fees and honoraria from AstraZeneca, Chiesi, GSK, Insmed, MSD/Merck, Novartis and Sanofi Regeneron for unbranded disease awareness and education. Aislinn Santoni, Suzanne Wait, Zachary Desson, Dawei Yang and Arzu Yorgancioglu declare that they have no conflicts of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.